Quest Diagnostics (NYSE:DGX) reported a strong quarterly performance supported by increased testing volumes and service ...
Phase two collaboration aims to expand access to streamlined genomic workflows for infectious disease researchSUNNYVALE, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results